Metformin exerts synergistic anti-proliferative effects with liraglutide in human umbilical vein endothelial cells (HUVECs)

OBJECTIVE(S): Metformin (Met) and liraglutide (Lira) have been approved to treat type 2 diabetes mellitus and have cardioprotective effects. MATERIALS AND METHODS: Human umbilical vein endothelial cells (HUVECs) were incubated with Met, Lira, or their combination in this study. RESULTS: Results show...

Descripción completa

Detalles Bibliográficos
Autores principales: Shadboorestan, Amir, Eftekhari, Samane, Mottaghi- Dastjerdi, Negar, Shahparvari, Rezvan, Tarighi, Parastoo, Jahandar, Hoda, Faghihi, Homa, Montazeri, Hamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150808/
https://www.ncbi.nlm.nih.gov/pubmed/35656067
http://dx.doi.org/10.22038/IJBMS.2022.64117.14117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150808/
https://www.ncbi.nlm.nih.gov/pubmed/35656067
http://dx.doi.org/10.22038/IJBMS.2022.64117.14117

Ejemplares similares